Azora Therapeutics surges 14% in regular trading

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Azora Therapeutics (AZR.US) surged nearly 14% during regular trading to $4.00.

The stock is down 18.03% over the past ten sessions, up 189.86% over the past six months and down 27.27% from its IPO price. It sits 205.34% above its 52-week low of US$1.310. The intraday swing reached 16.30%.

The Nasdaq Composite is up 4.25% over the past five sessions and up 9.07% year to date.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.